Massachusetts Financial Services’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-71,029
Closed -$1.88M – 998
2025
Q4
$1.88M Sell
71,029
-6,125
-8% -$118K ﹤0.01% 794
2025
Q3
$1.47M Sell
77,154
-595
-0.8% -$9.26K ﹤0.01% 782
2025
Q2
$1.51M Sell
77,749
-2,623
-3% -$50.9K ﹤0.01% 789
2025
Q1
$1.15M Buy
80,372
+292
+0.4% +$5.59K ﹤0.01% 798
2024
Q4
$1.98M Sell
80,080
-7,059
-8% -$197K ﹤0.01% 763
2024
Q3
$2.65M Buy
87,139
+4,107
+5% +$161K ﹤0.01% 709
2024
Q2
$4.25M Buy
83,032
+2,152
+3% +$166K ﹤0.01% 691
2024
Q1
$7.18M Buy
+80,880
New +$8.17M ﹤0.01% 647

Other funds holding GUTS

Massachusetts Financial Services's GUTS Position: Q1 2026 in Review

Massachusetts Financial Services sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 71,029 shares — an estimated $1.88M sold.

Massachusetts Financial Services first reported a position in GUTS in Q1 2024 and held it in 8 quarters. The position peaked at $7.18M in Q1 2024. 85 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Massachusetts Financial Services reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Massachusetts Financial Services sold 71,029 Fractyl Health shares in Q1 2026, an estimated $1.88M.
  • Massachusetts Financial Services first reported a position in Fractyl Health in Q1 2024 and held it in 8 quarters.
  • Massachusetts Financial Services's Fractyl Health position peaked at $7.18M in Q1 2024.
  • 85 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.